In conclusion, we believe that this is the first observation that fullerol, a potent antioxidant agent, suppresses IL-1 β-induced ROS and inflammatory cytokine production, inhibits the adipogenic differentiation of vBMSCs in vitro and, therefore, may prevent vertebral fatty marrow deposition and inflammatory responses during disc degeneration.